Press Releases

Mar 25, 2026

Nina Shah

Press Releases

Avalyn Announces Publication Demonstrating Correlation Between Imaging, Improved Lung Function, and Quality of Life with AP01 in Patients with Idiopathic Pulmonary Fibrosis

Avalyn Pharma announced peer-reviewed data from its Phase 1b ATLAS trial demonstrating that improvements in quantitative lung imaging correlate with better lung function and quality of life in patients with idiopathic pulmonary fibrosis treated with AP01. The findings mark the first dataset linking antifibrotic therapy imaging with clinical outcome…

AVPH

Mar 25, 2026

Priya Menon

Press Releases

Innovation Beverage Group Ltd. Announces Acquisition of Controlling Interest in BlockFuel Energy Inc. and Execution of Amended Merger Agreement

Innovation Beverage Group Ltd. (Nasdaq: IBG) announced it has acquired a 51% controlling stake in Texas-based BlockFuel Energy Inc. This acquisition is a significant milestone toward a proposed merger that will create a rising oil producer and power generation company focusing on US onshore oil and gas operations and power generation for high-perfo…

IBG

Mar 25, 2026

Sofia Navarro

Press Releases

ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026

ProQR Therapeutics announced a virtual investor and analyst event on April 8, 2026, to showcase its expanding RNA editing pipeline based on its proprietary Axiomer™ technology. The company plans to provide updates on the lead AX-0810 program targeting cholestatic diseases with anticipated initial Phase 1 data in the first half of 2026, unveil AX-08…

PRQR

Mar 25, 2026

Avery Klein

Press Releases

Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research

Incannex Healthcare has entered a partnership with the American Academy of Sleep Medicine Foundation to sponsor research in sleep apnea, reflecting its commitment to the field as it advances its lead investigational oral combination therapy, IHL-42X. The company recently achieved strong Phase 2 clinical results and received FDA Fast Track designati…

IXHL

Mar 25, 2026

Avery Klein

Press Releases

authID Announces OEM Partnership with IDV and Background Screening Tech Innovator for Enhanced Reusable Digital Identity Credentials

authID announced a strategic OEM partnership with a disruptive digital identity and continuous background screening tech company to embed its biometric identity verification and authentication technology into the partner's platform. This collaboration aims to provide organizations with reusable digital identity credentials that enable secure onboar…

AUID

Mar 25, 2026

Derek Hwang

Press Releases

LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia

LB Pharmaceuticals has commenced its pivotal Phase 3 NOVA-2 trial to evaluate LB-102, a novel oral benzamide antipsychotic candidate, for the treatment of schizophrenia in approximately 460 U.S. patients. LB-102 showed promising Phase 2 results with significant symptom improvement and a favorable safety profile. Topline data from NOVA-2 are expecte…

LBRX

Mar 25, 2026

Ajmal Hussain

Press Releases

Getty Realty Corp. to Report First Quarter 2026 Financial Results

Getty Realty Corp., a US-based net lease REIT focused on convenience and automotive retail real estate, will release its Q1 2026 financial results on April 22, 2026, and host a concurrent earnings call on April 23, 2026. The company's portfolio comprises 1,174 properties across 44 states and Washington, D.C.

GTY

Mar 25, 2026

Caleb Monroe

Press Releases

zSpace and Atlanta Public Schools Demonstrate a Decade of Impact Using AR/VR to Transform STEM and Career Education

zSpace, Inc. highlights a successful partnership with Atlanta Public Schools, demonstrating the transformative power of its AR/VR learning platform in enhancing STEM education and career readiness across multiple school levels over nearly ten years. The immersive technology facilitates hands-on learning experiences that prepare students for workfor…

ZSPC

Mar 25, 2026

Ajmal Hussain

Press Releases

BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine

BullFrog AI Holdings has introduced bfARENAS™, a new AI-powered decision engine designed to support pharmaceutical and biotech companies in optimizing portfolio strategies and clinical trial designs. The tool evaluates options under multiple strategic scenarios, aiming to reduce risk and improve R&D decision-making efficiency amid clinical trial un…

BFRG

Mar 25, 2026

Derek Hwang

Press Releases

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

Kestra Medical Technologies, a wearable medical device and digital healthcare firm, has been named a finalist in the 'Deal of the Year' category at the 2026 GeekWire Awards. The nomination recognizes Kestra's impactful 2025 initial public offering, which bolstered the company’s capacity to expand commercially and innovate its Cardiac Recovery Syste…

KMTS

Mar 25, 2026

Marcus Reed

Press Releases

Kaltura Achieves ISO/IEC 42001 Compliance Certification, The Global Standard for Secure and Trustworthy AI

Kaltura has obtained ISO/IEC 42001 certification, the global standard for Artificial Intelligence Management Systems, recognizing its ability to manage AI-related risks including security and operational misuse. This certification enhances trust in Kaltura’s AI offerings, especially for customers in regulated sectors like financial services, health…

KLTR

Mar 25, 2026

Nina Shah

Press Releases

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

Recursion, a clinical-stage TechBio company, announced that Dr. Vicki Goodman will become Chief Medical Officer on April 6, 2026, succeeding Dr. David Mauro. Dr. Goodman brings extensive oncology drug development expertise from roles at biotech and major pharma companies, enhancing Recursion's leadership as it advances its clinical pipeline and pre…

RXRX

Mar 25, 2026

Leila Farooq

Press Releases

Identity and Biometric Authentication Cybersecurity Provider BIO-key to Host Year-End Investor Call Tuesday, March 31st at 10am ET

BIO-key International, a leader in biometric authentication and identity access management solutions, announces its 2025 year-end earnings call scheduled for March 31st. The company will release financial results prior to the market opening, with senior executives hosting the conference call and Q&A session.

BKYI

Mar 25, 2026

Caleb Monroe

Press Releases

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

Artelo Biosciences announced a fully funded clinical study expanding its lead compound ART27.13 into the $16.3 billion glaucoma market, complementing its existing pipeline targeting oncology support, neuropathic pain, and CNS disorders. The company highlights positive interim Phase 2 data, European patent protection through 2041, supportive regulat…

ARTL

Mar 25, 2026

Jordan Park

Press Releases

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP TMS S.A. announced record fourth quarter and full-year 2025 revenue growth in its High-Intensity Focused Ultrasound (HIFU) business, with a 39% year-over-year increase driven by stronger global demand for the Focal One system. The company reported increased system sales, notably 14 cash sales in Q4, and 28% growth in U.S. Focal One procedures.…

EDAP

Mar 25, 2026

Marcus Reed

Press Releases

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

Anavex Life Sciences has withdrawn its application for European marketing authorization of blarcamesine as an add-on treatment for early Alzheimer's disease after the EMA's Committee for Medicinal Products for Human Use indicated it would not issue a positive opinion at this time. The company plans to gather additional data and conduct further anal…

AVXL

Mar 25, 2026

Hana Yamamoto

Press Releases

Creative Realities Appoints Jackie Walker as CXO to Lead Experience Strategy and Next Generation SaaS Platform Vision

Creative Realities, Inc. (NASDAQ: CREX), a leading provider of digital signage and AdTech solutions, has appointed Jackie Walker as Chief Experience Officer. With over 15 years’ experience in digital transformation and expertise in retail media networks and QSR digital merchandising, Walker will lead the company’s transition into a software-first p…

CREX

Mar 25, 2026

Avery Klein

Press Releases

Rekor Systems Appoints Marc Segal as Director of Rekor Command® to Drive Expansion in Key Growth Markets

Rekor Systems, a NASDAQ-listed leader in roadway intelligence systems, announced the appointment of Marc Segal as Technical Account Management Director for its Rekor Command® real-time traffic operations platform. Based in Austin, Texas, Segal's role aims to accelerate adoption and expand the platform’s presence, leveraging his expertise and existi…

REKR

Mar 25, 2026

Jordan Park

Press Releases

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

Vera Therapeutics, a Nasdaq-listed biotechnology firm focused on immunological diseases, announced the appointment of Jane Wright-Mitchell as Chief Legal Officer. Wright-Mitchell brings extensive experience in legal, compliance, and regulatory affairs within life sciences, positioning the company to support key milestones and the anticipated commer…

VERA

Mar 25, 2026

Caleb Monroe

Press Releases

Cipher Digital Announces Business Updates

Cipher Digital announces execution of a 15-year lease agreement for a new high-performance computing (HPC) data center campus with an investment-grade hyperscale tenant. The company also closed its first syndicated revolving credit facility of up to $200 million, enhancing liquidity and supporting growth initiatives. This strategic development rein…

CIFR

Mar 25, 2026

Marcus Reed

Press Releases

HBT Financial, Inc. Announces Addition to Board of Directors

HBT Financial, Inc. announced the appointment of Michael J. Morton to its Board of Directors effective April 1, 2026. Morton brings nearly 40 years of banking experience, including leadership roles at Bank of Montreal and MB Financial. This addition aims to strengthen HBT's leadership as it continues to grow its regional banking operations.

HBT

Mar 25, 2026

Sofia Navarro

Press Releases

Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights

Maze Therapeutics announced positive topline results from its Phase 2 HORIZON trial showing clinical proof-of-concept for MZE829 in APOL1-mediated kidney disease (AMKD). The company plans to advance MZE829 into pivotal trials and start two Phase 2 trials in 2026 for MZE782 targeting phenylketonuria (PKU) and chronic kidney disease (CKD). Maze also …

MAZE

Mar 25, 2026

Avery Klein

Press Releases

Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

Maze Therapeutics reported promising topline results from its Phase 2 HORIZON trial of MZE829, an oral dual-mechanism APOL1 inhibitor targeting APOL1-mediated kidney disease. Treatment resulted in a 35.6% mean reduction in proteinuria (uACR) at week 12 across a broad AMKD patient population, with enhanced efficacy in FSGS patients (61.8% reduction)…

MAZE

Mar 25, 2026

Leila Farooq

Press Releases

Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a significant board restructuring led by majority stockholders Inscobee Inc. and Apimeds Korea, who removed several directors and appointed new ones, including a new CEO. This followed disagreements over a prior merger with MindWave Innovations, with MindWave disputing the board chang…

APUS

Mar 25, 2026

Leila Farooq

Press Releases

Picard Medical Reports Full Year 2025 Financial Results

Picard Medical, parent company of SynCardia Systems, reported revenue growth of 12.5% in 2025 with total revenue of $4.9 million. Despite an operating loss of $13.3 million, the company improved its operating loss and increased cash reserves significantly following successful equity and debt financing. The SynCardia Total Artificial Heart continues…

PMI